Semi‐quantitative scoring of potentially predictive markers for endocrine treatment of breast cancer: a comparison between whole sections and tissue microarrays

Por Henriksen, Katrine L, Rasmussen, Birgitte B, Lykkesfeldt, Anne E, Møller, Susanne, Ejlertsen, Bent, Mouridsen, Henning T
Publicado em 2007

In situ aromatase expression in primary tumor is associated with estrogen receptor expression but is not predictive of response to endocrine therapy in advanced breast cancer

Por Lykkesfeldt, Anne E, Henriksen, Katrine L, Rasmussen, Birgitte B, Sasano, Hironobu, Evans, Dean B, Møller, Susanne, Ejlertsen, Bent, Mouridsen, Henning T
Publicado em 2009

Activated HER-receptors in predicting outcome of ER-positive breast cancer patients treated with adjuvant endocrine therapy

Por Larsen, Mathilde S., Bjerre, Karsten, Lykkesfeldt, Anne E., Giobbie-Hurder, Anita, Lænkholm, Anne-Vibeke, Henriksen, Katrine L., Ejlertsen, Bent, Rasmussen, Birgitte B.
Publicado em 2012

Prognostic value of Bcl-2 in two independent populations of estrogen receptor positive breast cancer patients treated with adjuvant endocrine therapy

Por LARSEN, MATHILDE S., BJERRE, KARSTEN, GIOBBIE-HURDER, ANITA, LÆNKHOLM, ANNE-VIBEKE, HENRIKSEN, KATRINE L., EJLERTSEN, BENT, LYKKESFELDT, ANNE E., RASMUSSEN, BIRGITTE B.
Publicado em 2012

DIVERGENT ESTROGEN RECEPTOR POSITIVE AND NEGATIVE BREAST CANCER TRENDS AND ETIOLOGIC HETEROGENEITY IN DENMARK

Por Anderson, William F., Rosenberg, Philip S., Petito, Lucia, Katki, Hormuzd A., Ejlertsen, Bent, Ewertz, Marianne, Rasmussen, Birgitte B., Jensen, Maj-Britt, Kroman, Niels
Publicado em 2013

Aurora kinase B is important for antiestrogen resistant cell growth and a potential biomarker for tamoxifen resistant breast cancer

Por Larsen, Sarah L, Yde, Christina W, Laenkholm, Anne-Vibeke, Rasmussen, Birgitte B, Duun-Henriksen, Anne Katrine, Bak, Martin, Lykkesfeldt, Anne E, Kirkegaard, Tove
Publicado no BMC Cancer (2015)